Merck & Co., Inc. (6MK.DE) XETRA
99.51
+1.05(+1.07%)
Currency In EUR
- General
- Statistics
- Historical Data
- Profile
- Financials
Merck & Co., Inc.
Address
2000 Galloping Hill Road
Rahway, NJ 07033
United States of America (the)
Phone
908 740 4000
Website
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
73000
First IPO Date
December 28, 2007
Key Executives
| Name | Title | Pay | Year Born |
| Robert Davis | Chairman, President & Chief Executive Officer | 3.97M | 1967 |
| Chirfi Guindo | Executive Vice President of Strategic Access, Policy & Communications | 1.32M | 1966 |
| Sanat Chattopadhyay | Executive Vice President & President of Merck Manufacturing Division | 1.78M | 1960 |
| Richard R. DeLuca Jr. | Executive Vice President & President of Merck Animal Health | 1.86M | 1963 |
| Jennifer L. Zachary | Executive Vice President & General Counsel | 1.86M | 1978 |
| Betty D. Larson | Executive Vice President & Chief Human Resources Officer | 1.97M | 1976 |
| Caroline Litchfield | Executive Vice President & Chief Financial Officer | 2.06M | 1969 |
| Dean Y. Li | Executive Vice President & President of Merck Research Laboratories | 2.57M | 1963 |
| Joerg Koglin | Senior VP & Head of General Medicine - Global Clinical Development | 0 | N/A |
| Eliav Barr | Chief Medical Officer & Head of Global Clinical Development of Merck Research Laboratories | 0 | 1965 |
| Eric H. Rubin | Senior Vice President of Global Clinical Oncology & Early-stage Oncology | 0 | 1960 |
| David Michael Williams | Executive Vice President and Chief Information & Digital Officer | 0 | 1969 |
| Johannes J. Oosthuizen | Executive VP and President of Oncology & MSD International | 0 | 1968 |
| Dalton E. Smart | Senior Vice President of Finance, Principal Accounting Officer & Global Controller | 0 | 1967 |
| Joseph Romanelli | Senior VP & President of MSD Human Health International | 0 | 1974 |
| Peter Dannenbaum | Vice President of Investor Relations | 0 | N/A |
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
